–
Mineralys Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
−29.2
FY23:
−81.2
FY24:
−166
FY25:
−142
millions USD
FY21:
0
FY22:
−21.8
FY23:
−160
FY24:
115
FY25:
−390
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
128
FY23:
203
FY24:
116
FY25:
591
millions USD
FY21:
–
FY22:
77.0
FY23:
−38.4
FY24:
64.8
FY25:
58.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.6
FY22:
–
FY23:
−81.2
FY24:
−166
FY25:
−142
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.